{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T01:08:45Z","timestamp":1776474525901,"version":"3.51.2"},"reference-count":64,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2022,7,24]],"date-time":"2022-07-24T00:00:00Z","timestamp":1658620800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"European Regional Development Fund (ERDF) Integrated Territorial Initiative","award":["ITI PI0048-2017"],"award-info":[{"award-number":["ITI PI0048-2017"]}]},{"name":"European Regional Development Fund (ERDF) Integrated Territorial Initiative","award":["ITI PI0017-2019"],"award-info":[{"award-number":["ITI PI0017-2019"]}]},{"name":"European Regional Development Fund (ERDF) Integrated Territorial Initiative","award":["PI0012-2019"],"award-info":[{"award-number":["PI0012-2019"]}]},{"name":"European Regional Development Fund (ERDF) Integrated Territorial Initiative","award":["PI-INBICA 2019-13"],"award-info":[{"award-number":["PI-INBICA 2019-13"]}]},{"name":"European Regional Development Fund (ERDF) Integrated Territorial Initiative","award":["2020-019"],"award-info":[{"award-number":["2020-019"]}]},{"name":"Spanish Society of Cardiology for Basic Research in Cardiology","award":["ITI PI0048-2017"],"award-info":[{"award-number":["ITI PI0048-2017"]}]},{"name":"Spanish Society of Cardiology for Basic Research in Cardiology","award":["ITI PI0017-2019"],"award-info":[{"award-number":["ITI PI0017-2019"]}]},{"name":"Spanish Society of Cardiology for Basic Research in Cardiology","award":["PI0012-2019"],"award-info":[{"award-number":["PI0012-2019"]}]},{"name":"Spanish Society of Cardiology for Basic Research in Cardiology","award":["PI-INBICA 2019-13"],"award-info":[{"award-number":["PI-INBICA 2019-13"]}]},{"name":"Spanish Society of Cardiology for Basic Research in Cardiology","award":["2020-019"],"award-info":[{"award-number":["2020-019"]}]},{"name":"Plan Propio de INIBICA","award":["ITI PI0048-2017"],"award-info":[{"award-number":["ITI PI0048-2017"]}]},{"name":"Plan Propio de INIBICA","award":["ITI PI0017-2019"],"award-info":[{"award-number":["ITI PI0017-2019"]}]},{"name":"Plan Propio de INIBICA","award":["PI0012-2019"],"award-info":[{"award-number":["PI0012-2019"]}]},{"name":"Plan Propio de INIBICA","award":["PI-INBICA 2019-13"],"award-info":[{"award-number":["PI-INBICA 2019-13"]}]},{"name":"Plan Propio de INIBICA","award":["2020-019"],"award-info":[{"award-number":["2020-019"]}]},{"name":"Foundation Progreso y Salud PEER","award":["ITI PI0048-2017"],"award-info":[{"award-number":["ITI PI0048-2017"]}]},{"name":"Foundation Progreso y Salud PEER","award":["ITI PI0017-2019"],"award-info":[{"award-number":["ITI PI0017-2019"]}]},{"name":"Foundation Progreso y Salud PEER","award":["PI0012-2019"],"award-info":[{"award-number":["PI0012-2019"]}]},{"name":"Foundation Progreso y Salud PEER","award":["PI-INBICA 2019-13"],"award-info":[{"award-number":["PI-INBICA 2019-13"]}]},{"name":"Foundation Progreso y Salud PEER","award":["2020-019"],"award-info":[{"award-number":["2020-019"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Atherosclerotic cardiovascular diseases (ASCVD) are the leading cause of morbidity and mortality in Western societies. Statins are the first-choice therapy for dislipidemias and are considered the cornerstone of ASCVD. Statin-associated muscle symptoms are the main reason for dropout of this treatment. There is an urgent need to identify new biomarkers with discriminative precision for diagnosing intolerance to statins (SI) in patients. MicroRNAs (miRNAs) have emerged as evolutionarily conserved molecules that serve as reliable biomarkers and regulators of multiple cellular events in cardiovascular diseases. In the current study, we evaluated plasma miRNAs as potential biomarkers to discriminate between the SI vs. non-statin intolerant (NSI) population. It is a multicenter, prospective, case-control study. A total of 179 differentially expressed circulating miRNAs were screened in two cardiovascular risk patient cohorts (high and very high risk): (i) NSI (n = 10); (ii) SI (n = 10). Ten miRNAs were identified as being overexpressed in plasma and validated in the plasma of NSI (n = 45) and SI (n = 39). Let-7c-5p, let-7d-5p, let-7f-5p, miR-376a-3p and miR-376c-3p were overexpressed in the plasma of SI patients. The receiver operating characteristic curve analysis supported the discriminative potential of the diagnosis. We propose a three-miRNA predictive fingerprint (let-7f, miR-376a-3p and miR-376c-3p) and several clinical variables (non-HDLc and years of dyslipidemia) for SI discrimination; this model achieves sensitivity, specificity and area under the receiver operating characteristic curve (AUC) of 83.67%, 88.57 and 89.10, respectively. In clinical practice, this set of miRNAs combined with clinical variables may discriminate between SI vs. NSI subjects. This multiparametric model may arise as a potential diagnostic biomarker with clinical value.<\/jats:p>","DOI":"10.3390\/ijms23158146","type":"journal-article","created":{"date-parts":[[2022,7,24]],"date-time":"2022-07-24T22:49:02Z","timestamp":1658702942000},"page":"8146","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A microRNA Signature for the Diagnosis of Statins Intolerance"],"prefix":"10.3390","volume":"23","author":[{"given":"Alipio","family":"Mangas","sequence":"first","affiliation":[{"name":"Research Unit, Biomedical Research and Innovation Institute of Cadiz (INiBICA), Puerta del Mar University Hospital, 11009 C\u00e1diz, Spain"},{"name":"Medicine Department, School of Medicine, University of Cadiz, 11002 C\u00e1diz, Spain"},{"name":"Lipid and Atherosclerotic Unit, Internal Medicine Department, Puerta del Mar University Hospital, 11009 Cadiz, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5344-6573","authenticated-orcid":false,"given":"Alexandra","family":"P\u00e9rez-Serra","sequence":"additional","affiliation":[{"name":"Cardiology Service, Hospital Josep Trueta, University of Girona, 17007 Girona, Spain"},{"name":"Cardiovascular Genetics Center, University of Girona-IDIBGI, 17007 Girona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9855-8173","authenticated-orcid":false,"given":"Fernando","family":"Bonet","sequence":"additional","affiliation":[{"name":"Research Unit, Biomedical Research and Innovation Institute of Cadiz (INiBICA), Puerta del Mar University Hospital, 11009 C\u00e1diz, Spain"},{"name":"Medicine Department, School of Medicine, University of Cadiz, 11002 C\u00e1diz, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ovidio","family":"Mu\u00f1iz","sequence":"additional","affiliation":[{"name":"UCERV, UCAMI, Servicio de Medicina Interna, Hospital Virgen del Roc\u00edo, 41013 Seville, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Fuentes","sequence":"additional","affiliation":[{"name":"Lipid and Atherosclerosis Unit, IMIBIC\/Hospital Universitario Reina Sof\u00eda\/Universidad de C\u00f3rdoba, 14004 C\u00f3rdoba, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red, Fisiopatologia Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurora","family":"Gonzalez-Estrada","sequence":"additional","affiliation":[{"name":"UCERV, UCAMI, Servicio de Medicina Interna, Hospital Virgen del Roc\u00edo, 41013 Seville, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar","family":"Campuzano","sequence":"additional","affiliation":[{"name":"Cardiology Service, Hospital Josep Trueta, University of Girona, 17007 Girona, Spain"},{"name":"Cardiovascular Genetics Center, University of Girona-IDIBGI, 17007 Girona, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red, Fisiopatologia Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red, Enfermedades Cardiovasculares (CIBERCV), 28029 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Sebastian","family":"Rodriguez Roca","sequence":"additional","affiliation":[{"name":"Lipid and Atherosclerotic Unit, Internal Medicine Department, Puerta del Mar University Hospital, 11009 Cadiz, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Alonso-Villa","sequence":"additional","affiliation":[{"name":"Research Unit, Biomedical Research and Innovation Institute of Cadiz (INiBICA), Puerta del Mar University Hospital, 11009 C\u00e1diz, Spain"},{"name":"Medicine Department, School of Medicine, University of Cadiz, 11002 C\u00e1diz, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rocio","family":"Toro","sequence":"additional","affiliation":[{"name":"Research Unit, Biomedical Research and Innovation Institute of Cadiz (INiBICA), Puerta del Mar University Hospital, 11009 C\u00e1diz, Spain"},{"name":"Medicine Department, School of Medicine, University of Cadiz, 11002 C\u00e1diz, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,7,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","article-title":"2016 ESC\/EAS Guidelines for the Management of Dyslipidaemias","volume":"37","author":"Catapano","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"ESC Scientific Document Group (2020). 2019 ESC\/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Cholesterol Treatment Trialists\u2019 (CTT) Collaboration, Baigent, C., Blackwell, L., Emberson, J., Holland, L.E., Reith, C., Bhala, N., Peto, R., Barnes, E.H., and Keech, A. (2010). Efficacy and safety of more intensive lowering of LDL cholesterol: A meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet, 376, 1670\u20131681.","DOI":"10.1016\/S0140-6736(10)61350-5"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ijcard.2016.09.075","article-title":"Statin non-adherence and residual cardiovascular risk: There is need for substantial improvement","volume":"225","author":"Banach","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.jacl.2014.03.004","article-title":"The National Lipid Association\u2019s Muscle Safety Expert Panel. An assessment by the Statin Muscle Safety Task Force: 2014 update","volume":"8","author":"Rosenson","year":"2014","journal-title":"J. Clin. Lipidol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s12944-019-1099-z","article-title":"Long-term statin persistence is poor among high-risk patients with dyslipidemia: A real-world administrative claims analysis","volume":"18","author":"Toth","year":"2019","journal-title":"Lipids Health Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/eurheartj\/ehv043","article-title":"European Atherosclerosis Society Consensus Panel (2015). Statin-associated muscle symptoms: Impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management","volume":"36","author":"Stroes","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"221","DOI":"10.7326\/M16-0838","article-title":"Continued Statin Prescriptions after Adverse Reactions and Patient Outcomes: A Cohort Study","volume":"167","author":"Zhang","year":"2017","journal-title":"Ann. Intern. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s12265-020-10040-5","article-title":"Cardiovascular Exosomes and MicroRNAs in Cardiovascular Physiology and Pathophysiology","volume":"14","author":"Henning","year":"2021","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1042\/BST20170037","article-title":"MicroRNA-based therapeutics in cardiovascular disease: Screening and delivery to the target","volume":"46","author":"Mellis","year":"2018","journal-title":"Biochem. Soc. Trans."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"107296","DOI":"10.1016\/j.carpath.2020.107296","article-title":"MicroRNAs: Roles in cardiovascular development and disease","volume":"50","author":"Kalayinia","year":"2021","journal-title":"Cardiovasc. Pathol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/aps.2018.35","article-title":"The circulating non-coding RNA landscape for biomarker research: Lessons and prospects from cardiovascular diseases","volume":"39","author":"Costa","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/s41569-019-0218-x","article-title":"RNA-based diagnostic and therapeutic strategies for cardiovascular disease","volume":"16","author":"Lu","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1161\/CIRCRESAHA.119.315856","article-title":"Preclinical and Clinical Development of Noncoding RNA Therapeutics for Cardiovascular Disease","volume":"126","author":"Huang","year":"2020","journal-title":"Circ. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cca.2016.12.031","article-title":"Relationship between circulating microRNA-30c with total- and LDL-cholesterol, their circulatory transportation and effect of statins","volume":"466","author":"Sodi","year":"2017","journal-title":"Clin. Chim. Acta."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejps.2018.02.007","article-title":"Statins differentially modulate microRNAs expression in peripheral cells of hyperlipidemic subjects: A pilot study","volume":"117","author":"Zambrano","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Stormo, C., Kringen, M.K., Lyle, R., Olstad, O.K., Sachse, D., Berg, J.P., and Piehler, A.P. (2014). RNA-sequencing analysis of HepG2 cells treated with atorvastatin. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0105836"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1007\/s43440-021-00241-3","article-title":"Effect of statins on lipid metabolism-related microRNA expression in HepG2 cells","volume":"73","author":"Cerda","year":"2021","journal-title":"Pharmacol. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"R67","DOI":"10.1530\/JOE-17-0002","article-title":"FoxO integration of insulin signaling with glucose and lipid metabolism","volume":"233","author":"Lee","year":"2017","journal-title":"J. Endocrinol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1113\/jphysiol.2008.164699","article-title":"Blunted Akt\/FOXO signalling and activation of genes controlling atrophy and fuel use in statin myopathy","volume":"587","author":"Mallinson","year":"2009","journal-title":"J. Physiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.amjmed.2011.12.013","article-title":"Adherence to drugs that prevent cardiovascular disease: Meta-analysis on 376,162 patients","volume":"125","author":"Naderi","year":"2012","journal-title":"Am. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Vinci, P., Panizon, E., Tosoni, L.M., Cerrato, C., Pellicori, F., Mearelli, F., Biasinutto, C., Fiotti, N., Di Girolamo, F.G., and Biolo, G. (2021). Statin-Associated Myopathy: Emphasis on Mechanisms and Targeted Therapy. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222111687"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jacl.2016.12.007","article-title":"Investigating the prevalence, predictors, and prognosis of suboptimal statin use early after a non-ST elevation acute coronary syndrome","volume":"11","author":"Turner","year":"2017","journal-title":"Clin. Lipidol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"207","DOI":"10.5551\/jat.RV17030","article-title":"Diagnosis and Management of Statin Intolerance","volume":"26","author":"Alonso","year":"2019","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1161\/CIRCULATIONAHA.112.136101","article-title":"Effect of statins on skeletal muscle function","volume":"127","author":"Parker","year":"2013","journal-title":"Circulation"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s10557-016-6680-3","article-title":"Algorithms to identify statin intolerance in Medicare administrative claim data","volume":"30","author":"Colantonio","year":"2016","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/j.cjca.2016.01.003","article-title":"Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Canadian Consensus Working Group Update","volume":"32","author":"Mancini","year":"2016","journal-title":"Can. J. Cardiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"704175","DOI":"10.3389\/fcvm.2021.704175","article-title":"MicroRNAs hsa-miR-618 and hsa-miR-297 Might Modulate the Pleiotropic Effects Exerted by Statins in Endothelial Cells through the Inhibition of ROCK2 Kinase: In-silico Approach","volume":"8","author":"Leal","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"7355","DOI":"10.1007\/s00018-021-03979-4","article-title":"MicroRNA-34a: The bad guy in age-related vascular diseases","volume":"78","author":"Raucci","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1080\/17425255.2020.1801634","article-title":"An updated review of pharmacokinetic drug interactions and pharmacogenetics of statins","volume":"16","author":"Hirota","year":"2020","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e13388","DOI":"10.1111\/eci.13388","article-title":"Statins: Epidrugs with effects on endothelial health?","volume":"50","author":"Mohammadzadeh","year":"2020","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1152\/physiolgenomics.00112.2017","article-title":"Identification of human skeletal muscle miRNA related to strength by high-throughput sequencing","volume":"50","author":"Mitchell","year":"2018","journal-title":"Physiol. Genom."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1101\/gad.925901","article-title":"TGF-beta inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3","volume":"15","author":"Liu","year":"2001","journal-title":"Genes. Dev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3389\/fimmu.2020.00151","article-title":"Estrogen Receptor, Inflammatory, and FOXO Transcription Factors Regulate Expression of Myasthenia Gravis-Associated Circulating microRNAs","volume":"11","author":"Fiorillo","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_35","first-page":"633","article-title":"Integrated bioinformatics analysis identifies microRNA-376a-3p as a new microRNA biomarker in patient with coronary artery disease","volume":"12","author":"Du","year":"2020","journal-title":"Am. J. Transl. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1152\/japplphysiol.00654.2015","article-title":"Influence of statins on distinct circulating microRNAs during prolonged aerobic exercise","volume":"120","author":"Min","year":"2016","journal-title":"J. Appl. Physiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"684","DOI":"10.3389\/fphys.2018.00684","article-title":"Phenotype-Specific Response of Circulating miRNAs Provides New Biomarkers of Slow or Fast Muscle Damage","volume":"9","author":"Siracusa","year":"2018","journal-title":"Front. Physiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"11470","DOI":"10.18632\/aging.202839","article-title":"Excessive expression of miR-1a by statin causes skeletal injury through targeting mitogen-activated protein kinase kinase kinase 1","volume":"13","author":"Fu","year":"2021","journal-title":"Aging"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/mus.23309","article-title":"Mitochondria of trained skeletal muscle are protected from deleterious effects of statins","volume":"46","author":"Bouitbir","year":"2012","journal-title":"Muscle. Nerve."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.jacbts.2019.03.012","article-title":"A Mechanism for Statin-Induced Susceptibility to Myopathy","volume":"4","author":"Lotteau","year":"2019","journal-title":"JACC Basic Transl. Sci."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Liu, L., Cao, P., Zhang, L., Qi, M., Wang, L., Li, Z., Shao, G., Ding, L., Zhao, X., and Zhao, X. (2021). Comparisons of adipogenesis- and lipid metabolism-related gene expression levels in muscle, adipose tissue and liver from Wagyu-cross and Holstein steers. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0247559"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"5577875","DOI":"10.1155\/2021\/5577875","article-title":"Qindan Capsule Attenuates Myocardial Hypertrophy and Fibrosis in Pressure Overload-Induced Mice Involving mTOR and TGF-\u03b21\/Smad Signaling Pathway Inhibition","volume":"2021","author":"Bai","year":"2021","journal-title":"Evid. Based Complementary Altern. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e22152","DOI":"10.1096\/fj.202101385RR","article-title":"FOXO1 cooperates with C\/EBP\u03b4 and ATF4 to regulate skeletal muscle atrophy transcriptional program during fasting","volume":"36","author":"Oyabu","year":"2022","journal-title":"FASEB J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e77610","DOI":"10.7554\/eLife.77610","article-title":"Lack of Tgfbr1 and Acvr1b synergistically stimulates myofibre hypertrophy and accelerates muscle regeneration","volume":"11","author":"Hillege","year":"2022","journal-title":"Elife"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/2044-5040-1-19","article-title":"Role of TGF-beta signalling in inherited and acquired myopathies","volume":"1","author":"Burks","year":"2011","journal-title":"Skelet. Muscle"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/molehr\/gau093","article-title":"Statins inhibit insulin-like growth factor action in first trimester placenta by altering insulin-like growth factor 1 receptor glycosylation","volume":"21","author":"Forbes","year":"2015","journal-title":"Mol. Hum. Reprod."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3892\/ol.2016.4569","article-title":"Statin induces apoptosis of human colon cancer cells and downregulation of insulin-like growth factor 1 receptor via proapoptotic ERK activation","volume":"12","author":"Jang","year":"2016","journal-title":"Oncol. Lett."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s12307-013-0129-z","article-title":"Inhibition of the insulin-like growth factor-1 receptor enhances effects of simvastatin on prostate cancer cells in co-culture with bone","volume":"6","author":"Nordstrand","year":"2013","journal-title":"Cancer Microenviron."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/j.bbamcr.2015.04.010","article-title":"The AKT\/mTOR signaling pathway plays a key role in statin-induced myotoxicity","volume":"1853","author":"Bonifacio","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"598166","DOI":"10.3389\/fphar.2020.598166","article-title":"Linalool Prevents Cisplatin Induced Muscle Atrophy by Regulating IGF-1\/Akt\/FoxO Pathway","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/eci.12461","article-title":"The role of mitochondria in statin-induced myopathy","volume":"45","author":"Apostolopoulou","year":"2015","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1177\/2047487314550804","article-title":"Muscle- and skeletal-related side-effects of statins: Tip of the iceberg?","volume":"23","author":"Auer","year":"2016","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/jcsm.12654","article-title":"Effects of statins on mitochondrial pathways","volume":"12","author":"Mollazadeh","year":"2021","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/MOL.0000000000000237","article-title":"Non-high-density lipoprotein cholesterol: Current status as cardiovascular marker","volume":"26","author":"Verbeek","year":"2015","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_55","unstructured":"SCORE2 working group and ESC Cardiovascular risk collaboration (2021). SCORE2 risk prediction algorithms: New models to estimate 10-year risk of cardiovascular disease in Europe. Eur. Heart J., 42, 2439\u20132454."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"SCORE2-OP working group and ESC Cardiovascular risk collaboration (2021). SCORE2-OP risk prediction algorithms: Estimating incident cardiovascular event risk in older persons in four geographical risk regions. Eur. Heart J., 42, 2455\u20132467.","DOI":"10.1093\/eurheartj\/ehab312"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.jacc.2015.02.020","article-title":"Effect of naturally random allocation to lower low-density lipoprotein cholesterol on the risk of coronary heart disease mediated by polymorphisms in NPC1L1, HMGCR, or both: A 2 \u00d7 2 factorial Mendelian randomization study","volume":"65","author":"Ference","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"5245","DOI":"10.1158\/0008-5472.CAN-04-0496","article-title":"Normalization of real-time quantitative reverse transcription-PCR data: A model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets","volume":"64","author":"Andersen","year":"2004","journal-title":"Cancer Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2020.01.003","article-title":"Peripheral microRNA panels to guide the diagnosis of familial cardiomyopathy","volume":"218","author":"Belmonte","year":"2020","journal-title":"Transl. Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"D419","DOI":"10.1093\/nar\/gky1038","article-title":"PANTHER version 14: More genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools","volume":"47","author":"Mi","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e00804","DOI":"10.1128\/mSystems.00804-20","article-title":"DOE JGI Metagenome Workflow","volume":"6","author":"Clum","year":"2021","journal-title":"Msystems"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: Protein\u2013protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"W199","DOI":"10.1093\/nar\/gkz401","article-title":"WebGestalt 2019: Gene set analysis toolkit with revamped UIs and APIs","volume":"47","author":"Liao","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Motulsky, H.J., and Brown, R.E. (2006). Detecting outliers when fitting data with nonlinear regression\u2014A new method based on robust nonlinear regression and the false discovery rate. BMC Bioinform., 7.","DOI":"10.1186\/1471-2105-7-123"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/15\/8146\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:55:43Z","timestamp":1760140543000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/15\/8146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,24]]},"references-count":64,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2022,8]]}},"alternative-id":["ijms23158146"],"URL":"https:\/\/doi.org\/10.3390\/ijms23158146","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,24]]}}}